Eos Management L.P. Buys 2,773 Shares of UnitedHealth Group Incorporated $UNH

Eos Management L.P. increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 57.3% during the fourth quarter, Holdings Channel reports. The firm owned 7,616 shares of the healthcare conglomerate’s stock after acquiring an additional 2,773 shares during the period. UnitedHealth Group makes up approximately 1.0% of Eos Management L.P.’s investment portfolio, making the stock its 24th biggest position. Eos Management L.P.’s holdings in UnitedHealth Group were worth $2,514,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the business. Teacher Retirement System of Texas boosted its stake in UnitedHealth Group by 11.8% in the fourth quarter. Teacher Retirement System of Texas now owns 255,768 shares of the healthcare conglomerate’s stock valued at $84,432,000 after buying an additional 27,087 shares in the last quarter. WP Advisors LLC boosted its stake in UnitedHealth Group by 2.8% in the fourth quarter. WP Advisors LLC now owns 24,233 shares of the healthcare conglomerate’s stock valued at $7,999,000 after buying an additional 664 shares in the last quarter. Mystic Asset Management Inc. boosted its stake in UnitedHealth Group by 8.1% in the fourth quarter. Mystic Asset Management Inc. now owns 6,140 shares of the healthcare conglomerate’s stock valued at $2,027,000 after buying an additional 458 shares in the last quarter. Schear Investment Advisers LLC boosted its stake in UnitedHealth Group by 7.6% in the fourth quarter. Schear Investment Advisers LLC now owns 5,269 shares of the healthcare conglomerate’s stock valued at $1,739,000 after buying an additional 370 shares in the last quarter. Finally, Amarillo National Bank acquired a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $294,000. 87.86% of the stock is owned by institutional investors and hedge funds.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q1 beat and outlook raise — UNH reported stronger-than-expected Q1 results (EPS beat, $111.7B revenue) and raised 2026 adjusted EPS guidance, which investors interpreted as evidence the turnaround is underway. VIEW: UnitedHealth’s strong first quarter, forecast raise cheer Wall Street (Reuters)
• Positive Sentiment: Analyst upgrades and target hikes — Several firms (Argus, Oppenheimer, RBC, Wells Fargo, Morgan Stanley and others) raised ratings/targets after the quarter, signaling broader buy-side confidence and providing further upside signals for the stock. These Analysts Increase Their Forecasts On UnitedHealth After Upbeat Earnings (Benzinga)
• Positive Sentiment: AI and operational investments — Management announced meaningful AI spending (reported ~$1.5B) and expansion of Optum Real transaction processing, positioning Optum as a higher-throughput, margin-enhancing platform over time. UnitedHealth’s AI Is Rebuilding the Payment Layer of American Healthcare (PYMNTS)
• Positive Sentiment: Bullish options flow — Unusually large call buying was recorded (roughly 164k calls), suggesting short-term investor optimism or hedging ahead of follow-through. (No direct article link available)
• Neutral Sentiment: Rural health initiative — The company launched a broad rural-health program to serve underserved communities; positive for long-term growth/PR but unlikely to move near-term earnings materially. UnitedHealth Launches Broad Rural Health Initiative (InsiderMonkey)
• Neutral Sentiment: Industry/peer lift — Strong UNH results boosted sentiment across insurers (CVS, Humana, Centene), but sector moves may contain idiosyncratic risks tied to medical-cost trends and policy. UnitedHealth Sets Sights on AI, Climbs (Yahoo Finance)
• Negative Sentiment: Policy/program uncertainty — UnitedHealth flagged challenges with a Medicare obesity-drug pilot, creating uncertainty about participation and near-term costs related to new drug coverage programs. UnitedHealth flags challenges in Medicare obesity drug pilot (Reuters)
• Negative Sentiment: Residual analyst caution — A few firms still express caution (e.g., Robert W. Baird maintains an underperform view with a lower target), reflecting lingering concerns about execution and medical-cost volatility. Analyst note listing (Benzinga)

Analyst Upgrades and Downgrades

A number of analysts have recently commented on UNH shares. Argus raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 price target on the stock in a research note on Wednesday. Weiss Ratings lowered UnitedHealth Group from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, March 2nd. Royal Bank Of Canada lifted their price objective on UnitedHealth Group from $361.00 to $400.00 and gave the stock an “outperform” rating in a research note on Wednesday. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price objective on the stock in a research note on Tuesday, April 7th. Finally, JPMorgan Chase & Co. lowered their target price on UnitedHealth Group from $425.00 to $389.00 and set an “overweight” rating for the company in a report on Monday, February 2nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $377.68.

UnitedHealth Group Stock Performance

NYSE UNH opened at $353.51 on Thursday. The company has a fifty day simple moving average of $290.76 and a 200 day simple moving average of $317.09. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $438.85. The company has a current ratio of 0.80, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The company has a market cap of $320.88 billion, a P/E ratio of 26.70, a PEG ratio of 1.53 and a beta of 0.40.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The business had revenue of $111.65 billion during the quarter, compared to the consensus estimate of $109.84 billion. During the same quarter last year, the firm posted $7.20 EPS. UnitedHealth Group’s revenue was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 18.43 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Investors of record on Monday, March 9th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, March 9th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio is 67.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.